Gene-guided medication for mood disorder in chronic kidney disease
Part of Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This study looks at how your genes affect medications for mood disorders, like depression or anxiety, if you also have chronic kidney disease (CKD). The goal is to find the best medicine for you with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have chronic kidney disease (CKD).
- You must be between 18 and 90 years old.
- This study looks at mood disorders and how your genes might affect treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether doing genetic testing before starting or adjusting antidepressants—guided by a pharmacist—can improve treatment for people with moderate to severe depression. The goal is to help match you with antidepressants more safely and effectively.
This study tests different ways of reminding doctors about medicines that can help protect the kidneys in people with chronic kidney disease. If you join, your doctor may get extra information about treatments that could slow down kidney damage.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This study tests whether nurses can effectively screen for depression in patients receiving regular kidney dialysis treatment. The goal is to find the best way to identify depression early so patients can get help.
This study compares a personalized medication plan based on your genes versus standard dosing for people with depression, anxiety, or psychosis. It may help your clinician choose a safer or more effective dose or medicine by using pharmacogenomics (gene-informed prescribing).
This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.